NO862159L - Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater.Info
- Publication number
- NO862159L NO862159L NO862159A NO862159A NO862159L NO 862159 L NO862159 L NO 862159L NO 862159 A NO862159 A NO 862159A NO 862159 A NO862159 A NO 862159A NO 862159 L NO862159 L NO 862159L
- Authority
- NO
- Norway
- Prior art keywords
- methyl
- amino
- benzazepin
- dimethoxy
- group
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 13
- 238000000034 method Methods 0.000 title claims description 10
- 150000001412 amines Chemical class 0.000 title description 4
- 230000001225 therapeutic effect Effects 0.000 title 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 284
- 239000001294 propane Substances 0.000 claims description 177
- -1 heteroaromatic amine Chemical class 0.000 claims description 108
- 150000001875 compounds Chemical class 0.000 claims description 54
- 239000000460 chlorine Substances 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 23
- 125000004432 carbon atom Chemical group C* 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 18
- 239000001257 hydrogen Substances 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 230000001681 protective effect Effects 0.000 claims description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 14
- 150000007522 mineralic acids Chemical class 0.000 claims description 12
- 150000007524 organic acids Chemical class 0.000 claims description 12
- 235000005985 organic acids Nutrition 0.000 claims description 11
- 229910052801 chlorine Inorganic materials 0.000 claims description 10
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 9
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 125000003282 alkyl amino group Chemical group 0.000 claims description 8
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 150000001721 carbon Chemical group 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000001072 heteroaryl group Chemical group 0.000 claims description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 4
- 230000000269 nucleophilic effect Effects 0.000 claims description 4
- 125000002071 phenylalkoxy group Chemical group 0.000 claims description 4
- 125000006239 protecting group Chemical group 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 125000004414 alkyl thio group Chemical group 0.000 claims description 3
- 239000003638 chemical reducing agent Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 3
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 3
- 150000001204 N-oxides Chemical class 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 125000004849 alkoxymethyl group Chemical group 0.000 claims description 2
- 125000005530 alkylenedioxy group Chemical group 0.000 claims description 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 2
- 125000005946 imidazo[1,2-a]pyridyl group Chemical group 0.000 claims description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 189
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 147
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 113
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 59
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 47
- 239000000741 silica gel Substances 0.000 description 47
- 229910002027 silica gel Inorganic materials 0.000 description 47
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 40
- UKLLLQWDPVQNPO-UHFFFAOYSA-N 3-(3-chloropropyl)-7,8-dimethoxy-2,5-dihydro-1h-3-benzazepin-4-one Chemical compound C1CN(CCCCl)C(=O)CC2=C1C=C(OC)C(OC)=C2 UKLLLQWDPVQNPO-UHFFFAOYSA-N 0.000 description 39
- 238000002844 melting Methods 0.000 description 39
- 230000008018 melting Effects 0.000 description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 36
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 31
- 238000001556 precipitation Methods 0.000 description 29
- 125000005605 benzo group Chemical group 0.000 description 23
- 239000000243 solution Substances 0.000 description 22
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 20
- 229960000583 acetic acid Drugs 0.000 description 19
- 239000012458 free base Substances 0.000 description 19
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- KGMXPXPXPAAUMD-UHFFFAOYSA-N propane;dihydrochloride Chemical compound Cl.Cl.CCC KGMXPXPXPAAUMD-UHFFFAOYSA-N 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 239000012362 glacial acetic acid Substances 0.000 description 14
- 238000010992 reflux Methods 0.000 description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 14
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 11
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 239000003480 eluent Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 9
- 235000011121 sodium hydroxide Nutrition 0.000 description 9
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 239000003513 alkali Substances 0.000 description 8
- 238000009835 boiling Methods 0.000 description 8
- 239000005457 ice water Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 7
- 238000003776 cleavage reaction Methods 0.000 description 7
- UMSVPCYSAUKCAZ-UHFFFAOYSA-N propane;hydrochloride Chemical compound Cl.CCC UMSVPCYSAUKCAZ-UHFFFAOYSA-N 0.000 description 7
- 230000007017 scission Effects 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- CPNZASIAJKSBBH-UHFFFAOYSA-N 7,8-dimethoxy-1,3-dihydro-3-benzazepin-2-one Chemical compound C1C(=O)NC=CC2=C1C=C(OC)C(OC)=C2 CPNZASIAJKSBBH-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229940093915 gynecological organic acid Drugs 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000012279 sodium borohydride Substances 0.000 description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 description 5
- 239000011877 solvent mixture Substances 0.000 description 5
- 125000001544 thienyl group Chemical group 0.000 description 5
- 229930192474 thiophene Natural products 0.000 description 5
- ODEZTTCXWTUAJT-UHFFFAOYSA-N 3-(3-chloropropyl)-7,8-dimethoxy-1h-3-benzazepin-2-one Chemical compound C1C(=O)N(CCCCl)C=CC2=C1C=C(OC)C(OC)=C2 ODEZTTCXWTUAJT-UHFFFAOYSA-N 0.000 description 4
- IOZJGVXYRVTLON-UHFFFAOYSA-N 3-(7,8-dimethoxy-2-oxo-1h-3-benzazepin-3-yl)propanal Chemical compound C1C(=O)N(CCC=O)C=CC2=C1C=C(OC)C(OC)=C2 IOZJGVXYRVTLON-UHFFFAOYSA-N 0.000 description 4
- WQSGLEUNSRTJDG-UHFFFAOYSA-N 7,8-dimethoxy-3-[3-(methylamino)propyl]-2,5-dihydro-1h-3-benzazepin-4-one Chemical compound C1C(=O)N(CCCNC)CCC2=CC(OC)=C(OC)C=C21 WQSGLEUNSRTJDG-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 4
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- 238000005984 hydrogenation reaction Methods 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 4
- 239000012312 sodium hydride Substances 0.000 description 4
- 229910000104 sodium hydride Inorganic materials 0.000 description 4
- DQFQCHIDRBIESA-UHFFFAOYSA-N 1-benzazepine Chemical compound N1C=CC=CC2=CC=CC=C12 DQFQCHIDRBIESA-UHFFFAOYSA-N 0.000 description 3
- UWWLQUATUMACJU-UHFFFAOYSA-N 2-(1-benzothiophen-3-yl)-n-methylethanamine Chemical compound C1=CC=C2C(CCNC)=CSC2=C1 UWWLQUATUMACJU-UHFFFAOYSA-N 0.000 description 3
- QYRROBPCVBPJJS-UHFFFAOYSA-N 2-(furan-2-yl)-n-methylethanamine Chemical compound CNCCC1=CC=CO1 QYRROBPCVBPJJS-UHFFFAOYSA-N 0.000 description 3
- JPUAXUCTYGSBJN-UHFFFAOYSA-N 7,8-dimethoxy-1,5-dihydro-3-benzazepine-2,4-dione Chemical compound C1C(=O)NC(=O)CC2=C1C=C(OC)C(OC)=C2 JPUAXUCTYGSBJN-UHFFFAOYSA-N 0.000 description 3
- BMTAFVWTTFSTOG-UHFFFAOYSA-N Butylate Chemical compound CCSC(=O)N(CC(C)C)CC(C)C BMTAFVWTTFSTOG-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 229910052987 metal hydride Inorganic materials 0.000 description 3
- 150000004681 metal hydrides Chemical class 0.000 description 3
- QZBUGNURVLWJPK-UHFFFAOYSA-N n-methyl-2-pyridin-4-ylethanamine Chemical compound CNCCC1=CC=NC=C1 QZBUGNURVLWJPK-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 2
- VAZUVSAEURIXET-UHFFFAOYSA-N 1,5-dihydro-3-benzazepine-2,4-dione Chemical compound C1C(=O)NC(=O)CC2=CC=CC=C21 VAZUVSAEURIXET-UHFFFAOYSA-N 0.000 description 2
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical group CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 2
- OIEQWZXDRGOGHA-UHFFFAOYSA-N 2,4-bis(methylsulfanyl)-2,4-bis(sulfanylidene)-1,3,2$l^{5},4$l^{5}-dithiadiphosphetane Chemical compound CSP1(=S)SP(=S)(SC)S1 OIEQWZXDRGOGHA-UHFFFAOYSA-N 0.000 description 2
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 2
- QBJIMTPENIGDOG-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)acetyl chloride Chemical compound COC1=CC=C(CC(Cl)=O)C=C1OC QBJIMTPENIGDOG-UHFFFAOYSA-N 0.000 description 2
- WTGOUHQBRQKXTR-UHFFFAOYSA-N 2-(6,7-dimethoxyisoquinolin-4-yl)-n-methylethanamine Chemical compound COC1=C(OC)C=C2C(CCNC)=CN=CC2=C1 WTGOUHQBRQKXTR-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- JXPBXNVHBSZTNR-UHFFFAOYSA-N 3-(3,3-diethoxypropyl)-7,8-dimethoxy-1h-3-benzazepin-2-one Chemical compound C1C(=O)N(CCC(OCC)OCC)C=CC2=CC(OC)=C(OC)C=C21 JXPBXNVHBSZTNR-UHFFFAOYSA-N 0.000 description 2
- WNNCGBCTYXXAPB-UHFFFAOYSA-N 3-(3-chloropropyl)-7,8-dimethoxy-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1CN(CCCCl)CCC2=C1C=C(OC)C(OC)=C2 WNNCGBCTYXXAPB-UHFFFAOYSA-N 0.000 description 2
- AWNGYQGDURXVGR-UHFFFAOYSA-N 3-(3-chloropropyl)-8-methoxy-2,5-dihydro-1h-3-benzazepin-4-one Chemical compound C1C(=O)N(CCCCl)CCC2=CC(OC)=CC=C21 AWNGYQGDURXVGR-UHFFFAOYSA-N 0.000 description 2
- OMSUDKSFVPBUPY-UHFFFAOYSA-N 3-(7,8-dimethoxy-2,4-dioxo-1,5-dihydro-3-benzazepin-3-yl)propanal Chemical compound C1C(=O)N(CCC=O)C(=O)CC2=C1C=C(OC)C(OC)=C2 OMSUDKSFVPBUPY-UHFFFAOYSA-N 0.000 description 2
- OBGFCRHZMSQCOL-UHFFFAOYSA-N 3-(7,8-dimethoxy-4-oxo-2,5-dihydro-1h-3-benzazepin-3-yl)propanal Chemical compound C1CN(CCC=O)C(=O)CC2=C1C=C(OC)C(OC)=C2 OBGFCRHZMSQCOL-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- 125000005977 3-phenylpropyloxy group Chemical group 0.000 description 2
- YGXOOTPPQSPEHE-UHFFFAOYSA-N 4-bromo-1h-3-benzazepin-2-amine;hydrobromide Chemical compound Br.C1C(N)=NC(Br)=CC2=CC=CC=C21 YGXOOTPPQSPEHE-UHFFFAOYSA-N 0.000 description 2
- OTNUUORGIIRNSO-UHFFFAOYSA-N 4-bromo-7,8-dimethoxy-1h-3-benzazepin-2-amine;hydrobromide Chemical compound Br.C1C(N)=NC(Br)=CC2=C1C=C(OC)C(OC)=C2 OTNUUORGIIRNSO-UHFFFAOYSA-N 0.000 description 2
- RXKTVGMZJMDNLF-UHFFFAOYSA-N 7,8-dimethoxy-1,2,3,5-tetrahydro-3-benzazepin-4-one Chemical compound C1CNC(=O)CC2=C1C=C(OC)C(OC)=C2 RXKTVGMZJMDNLF-UHFFFAOYSA-N 0.000 description 2
- WUNQZFYRIABBKP-UHFFFAOYSA-N 7-methoxy-1,2,3,5-tetrahydro-3-benzazepin-4-one Chemical compound C1CNC(=O)CC2=CC(OC)=CC=C21 WUNQZFYRIABBKP-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- ZQIYRIXYCQWHON-UHFFFAOYSA-N 8-bromo-3-(3-chloropropyl)-7-methoxy-2,5-dihydro-1h-3-benzazepin-4-one Chemical compound C1C(=O)N(CCCCl)CCC2=C1C=C(OC)C(Br)=C2 ZQIYRIXYCQWHON-UHFFFAOYSA-N 0.000 description 2
- MDJWQMCLZVGKAU-UHFFFAOYSA-N 8-methoxy-1,2,3,5-tetrahydro-3-benzazepin-4-one Chemical compound C1C(=O)NCCC2=CC(OC)=CC=C21 MDJWQMCLZVGKAU-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002366 halogen compounds Chemical class 0.000 description 2
- WUAXWQRULBZETB-UHFFFAOYSA-N homoveratric acid Chemical compound COC1=CC=C(CC(O)=O)C=C1OC WUAXWQRULBZETB-UHFFFAOYSA-N 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- BYIGDPKFPQSZOO-UHFFFAOYSA-N n-(2,2-dimethoxyethyl)-2-(3,4-dimethoxyphenyl)acetamide Chemical compound COC(OC)CNC(=O)CC1=CC=C(OC)C(OC)=C1 BYIGDPKFPQSZOO-UHFFFAOYSA-N 0.000 description 2
- AEDKVYNEHDRQEG-UHFFFAOYSA-N n-[2-(furan-2-yl)ethyl]formamide Chemical compound O=CNCCC1=CC=CO1 AEDKVYNEHDRQEG-UHFFFAOYSA-N 0.000 description 2
- WKRUEUNOCVALAM-UHFFFAOYSA-N n-methyl-2-pyridin-3-ylethanamine Chemical compound CNCCC1=CC=CN=C1 WKRUEUNOCVALAM-UHFFFAOYSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 150000007530 organic bases Chemical group 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical class [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- SFOYQZYQTQDRIY-UHFFFAOYSA-N 1-chloro-3-iodopropane Chemical compound ClCCCI SFOYQZYQTQDRIY-UHFFFAOYSA-N 0.000 description 1
- QKWWDTYDYOFRJL-UHFFFAOYSA-N 2,2-dimethoxyethanamine Chemical compound COC(CN)OC QKWWDTYDYOFRJL-UHFFFAOYSA-N 0.000 description 1
- ALBMLVMWCMVAQF-UHFFFAOYSA-N 2-(1-benzofuran-2-yl)-n-methylethanamine Chemical compound C1=CC=C2OC(CCNC)=CC2=C1 ALBMLVMWCMVAQF-UHFFFAOYSA-N 0.000 description 1
- ZLVRUPSQLDHCJF-UHFFFAOYSA-N 2-(2,5-dimethylthiophen-3-yl)-n-methylethanamine Chemical compound CNCCC=1C=C(C)SC=1C ZLVRUPSQLDHCJF-UHFFFAOYSA-N 0.000 description 1
- ZHZWGOXGMBXQKY-UHFFFAOYSA-N 2-(2-benzylbenzimidazol-1-yl)-n-methylethanamine Chemical compound N=1C2=CC=CC=C2N(CCNC)C=1CC1=CC=CC=C1 ZHZWGOXGMBXQKY-UHFFFAOYSA-N 0.000 description 1
- JMIUKTQZYNBSJP-UHFFFAOYSA-N 2-(4-methoxy-1-benzofuran-3-yl)-n-methylethanamine Chemical compound C1=CC(OC)=C2C(CCNC)=COC2=C1 JMIUKTQZYNBSJP-UHFFFAOYSA-N 0.000 description 1
- ZFJMRPPGAVQVNH-UHFFFAOYSA-N 2-(4-methoxy-1-benzothiophen-3-yl)-n-methylethanamine Chemical compound C1=CC(OC)=C2C(CCNC)=CSC2=C1 ZFJMRPPGAVQVNH-UHFFFAOYSA-N 0.000 description 1
- FTFHRQQYHHLRRP-UHFFFAOYSA-N 2-(5,6-dimethoxy-1-benzothiophen-3-yl)-n-methylethanamine Chemical compound COC1=C(OC)C=C2C(CCNC)=CSC2=C1 FTFHRQQYHHLRRP-UHFFFAOYSA-N 0.000 description 1
- ZVRDSJOIHGNECZ-UHFFFAOYSA-N 2-(5-bromo-1-benzothiophen-3-yl)-n-methylethanamine Chemical compound C1=C(Br)C=C2C(CCNC)=CSC2=C1 ZVRDSJOIHGNECZ-UHFFFAOYSA-N 0.000 description 1
- NXORUJLPZCPOQK-UHFFFAOYSA-N 2-(6-methoxy-1-benzofuran-3-yl)-n-methylethanamine Chemical compound COC1=CC=C2C(CCNC)=COC2=C1 NXORUJLPZCPOQK-UHFFFAOYSA-N 0.000 description 1
- QKFNNIHXMOSSRH-UHFFFAOYSA-N 2-(6-methoxy-1-benzothiophen-3-yl)-n-methylethanamine Chemical compound COC1=CC=C2C(CCNC)=CSC2=C1 QKFNNIHXMOSSRH-UHFFFAOYSA-N 0.000 description 1
- MTRUYNRSNFSQND-UHFFFAOYSA-N 2-(benzimidazol-1-yl)-n-methylethanamine Chemical compound C1=CC=C2N(CCNC)C=NC2=C1 MTRUYNRSNFSQND-UHFFFAOYSA-N 0.000 description 1
- ZQSLNSHMUQXSQJ-UHFFFAOYSA-N 2-(furan-2-yl)ethanamine Chemical compound NCCC1=CC=CO1 ZQSLNSHMUQXSQJ-UHFFFAOYSA-N 0.000 description 1
- CLPUHDRCBSUDOU-UHFFFAOYSA-N 2-[2-(cyanomethyl)-3,4-dimethoxyphenyl]acetonitrile Chemical compound COC1=CC=C(CC#N)C(CC#N)=C1OC CLPUHDRCBSUDOU-UHFFFAOYSA-N 0.000 description 1
- FWPFXBANOKKNBR-UHFFFAOYSA-N 2-[2-(cyanomethyl)phenyl]acetonitrile Chemical compound N#CCC1=CC=CC=C1CC#N FWPFXBANOKKNBR-UHFFFAOYSA-N 0.000 description 1
- HPHJTWKPQRPOLN-UHFFFAOYSA-N 2-chloro-n-[2-(3-methoxyphenyl)ethyl]acetamide Chemical compound COC1=CC=CC(CCNC(=O)CCl)=C1 HPHJTWKPQRPOLN-UHFFFAOYSA-N 0.000 description 1
- UUHRZOGUDROUKQ-UHFFFAOYSA-N 2-imidazol-1-yl-n-methylethanamine Chemical compound CNCCN1C=CN=C1 UUHRZOGUDROUKQ-UHFFFAOYSA-N 0.000 description 1
- JHWIEAWILPSRMU-UHFFFAOYSA-N 2-methyl-3-pyrimidin-4-ylpropanoic acid Chemical compound OC(=O)C(C)CC1=CC=NC=N1 JHWIEAWILPSRMU-UHFFFAOYSA-N 0.000 description 1
- 125000005975 2-phenylethyloxy group Chemical group 0.000 description 1
- CDQIHTLLGFKDGK-UHFFFAOYSA-N 3-(1-benzothiophen-3-yl)-n-methylpropan-1-amine Chemical compound C1=CC=C2C(CCCNC)=CSC2=C1 CDQIHTLLGFKDGK-UHFFFAOYSA-N 0.000 description 1
- NBHLIEQTUQUZCI-UHFFFAOYSA-N 3-(2-chloroethyl)-1-benzothiophen-6-ol Chemical compound OC1=CC=C2C(CCCl)=CSC2=C1 NBHLIEQTUQUZCI-UHFFFAOYSA-N 0.000 description 1
- FYYFNDPTBNPSGY-UHFFFAOYSA-N 3-(3-chloropropyl)-1,5-dihydro-3-benzazepine-2,4-dione Chemical compound C1C(=O)N(CCCCl)C(=O)CC2=CC=CC=C21 FYYFNDPTBNPSGY-UHFFFAOYSA-N 0.000 description 1
- FBELYCHTFIPIET-UHFFFAOYSA-N 3-(3-chloropropyl)-1-oxidopyridin-1-ium Chemical compound [O-][N+]1=CC=CC(CCCCl)=C1 FBELYCHTFIPIET-UHFFFAOYSA-N 0.000 description 1
- MGFLPGXFTYNLOR-UHFFFAOYSA-N 3-(3-chloropropyl)-7,8-dimethoxy-1,2-dihydro-3-benzazepine-4,5-dione Chemical compound C1CN(CCCCl)C(=O)C(=O)C2=C1C=C(OC)C(OC)=C2 MGFLPGXFTYNLOR-UHFFFAOYSA-N 0.000 description 1
- JQNNDIZTOXOQME-UHFFFAOYSA-N 3-(3-chloropropyl)-7-methoxy-2,5-dihydro-1h-3-benzazepin-4-one Chemical compound C1CN(CCCCl)C(=O)CC2=CC(OC)=CC=C21 JQNNDIZTOXOQME-UHFFFAOYSA-N 0.000 description 1
- PLSAGCBMUYIWFV-UHFFFAOYSA-N 3-(3-chloropropyl)-7-methoxy-8-nitro-2,5-dihydro-1h-3-benzazepin-4-one Chemical compound C1C(=O)N(CCCCl)CCC2=C1C=C(OC)C([N+]([O-])=O)=C2 PLSAGCBMUYIWFV-UHFFFAOYSA-N 0.000 description 1
- JIXGRXJTSCZWNB-UHFFFAOYSA-N 3-(chloromethyl)-1-benzothiophene Chemical compound C1=CC=C2C(CCl)=CSC2=C1 JIXGRXJTSCZWNB-UHFFFAOYSA-N 0.000 description 1
- GKIUEIPANNQGFU-UHFFFAOYSA-N 3-(furan-2-yl)-n-methylpropan-1-amine Chemical compound CNCCCC1=CC=CO1 GKIUEIPANNQGFU-UHFFFAOYSA-N 0.000 description 1
- NXHONHDWVLPPCS-UHFFFAOYSA-N 3-chloro-1,1-diethoxypropane Chemical compound CCOC(CCCl)OCC NXHONHDWVLPPCS-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- NIFAUKBQIAURIM-UHFFFAOYSA-N 4-(chloromethyl)-3,5-dimethyl-1,2-oxazole Chemical compound CC1=NOC(C)=C1CCl NIFAUKBQIAURIM-UHFFFAOYSA-N 0.000 description 1
- DZLYXZAZLVJKIN-UHFFFAOYSA-N 6-bromo-7-methoxy-1,2,3,5-tetrahydro-3-benzazepin-4-one Chemical compound C1CNC(=O)CC2=C(Br)C(OC)=CC=C21 DZLYXZAZLVJKIN-UHFFFAOYSA-N 0.000 description 1
- WKNIIWMIHHBOEY-UHFFFAOYSA-N 7,8-dimethoxy-2,3-dihydro-1h-3-benzazepine Chemical compound C1CNC=CC2=C1C=C(OC)C(OC)=C2 WKNIIWMIHHBOEY-UHFFFAOYSA-N 0.000 description 1
- AMUXOOATRHJXHN-UHFFFAOYSA-N 7,8-dimethoxy-3-[3-(methylamino)propyl]-2,5-dihydro-1h-3-benzazepin-4-one;hydrochloride Chemical compound Cl.C1C(=O)N(CCCNC)CCC2=CC(OC)=C(OC)C=C21 AMUXOOATRHJXHN-UHFFFAOYSA-N 0.000 description 1
- PWSVUWAGTWPYDK-UHFFFAOYSA-N 7,8-dimethyl-1,3-dihydro-3-benzazepin-2-one Chemical compound C1C(=O)NC=CC2=C1C=C(C)C(C)=C2 PWSVUWAGTWPYDK-UHFFFAOYSA-N 0.000 description 1
- NMAFAHYJVZHPOO-UHFFFAOYSA-N 8-bromo-7-methoxy-1,2,3,5-tetrahydro-3-benzazepin-4-one Chemical compound C1C(=O)NCCC2=C1C=C(OC)C(Br)=C2 NMAFAHYJVZHPOO-UHFFFAOYSA-N 0.000 description 1
- HXVHXRSJKKNETO-UHFFFAOYSA-N 8-methoxy-1,3-dihydro-1-benzazepin-2-one Chemical compound C1=CCC(=O)NC2=CC(OC)=CC=C21 HXVHXRSJKKNETO-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PQQKNRVHFHKIEY-UHFFFAOYSA-N Cl.Cl.Cl.CCC Chemical compound Cl.Cl.Cl.CCC PQQKNRVHFHKIEY-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 208000007888 Sinus Tachycardia Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- QYHYQHPUNPVNDV-UHFFFAOYSA-N aluminane Chemical compound C1CC[AlH]CC1 QYHYQHPUNPVNDV-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- UUQMNUMQCIQDMZ-UHFFFAOYSA-N betahistine Chemical compound CNCCC1=CC=CC=N1 UUQMNUMQCIQDMZ-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910001622 calcium bromide Inorganic materials 0.000 description 1
- WGEFECGEFUFIQW-UHFFFAOYSA-L calcium dibromide Chemical compound [Ca+2].[Br-].[Br-] WGEFECGEFUFIQW-UHFFFAOYSA-L 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229940116364 hard fat Drugs 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- NGHGUGCWVFQMFY-UHFFFAOYSA-N n-(2,2-dimethoxyethyl)-2-(2,5-dimethoxyphenyl)acetamide Chemical compound COC(OC)CNC(=O)CC1=CC(OC)=CC=C1OC NGHGUGCWVFQMFY-UHFFFAOYSA-N 0.000 description 1
- KDQRRJWDFBZCKZ-UHFFFAOYSA-N n-(2,2-dimethoxyethyl)-2-(3,4-dimethylphenyl)acetamide Chemical compound COC(OC)CNC(=O)CC1=CC=C(C)C(C)=C1 KDQRRJWDFBZCKZ-UHFFFAOYSA-N 0.000 description 1
- IACWINFPRKNWLW-UHFFFAOYSA-N n-benzyl-2-(5-methoxy-3-methyl-1-benzofuran-2-yl)ethanamine Chemical compound CC=1C2=CC(OC)=CC=C2OC=1CCNCC1=CC=CC=C1 IACWINFPRKNWLW-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- RGYJBKFFLRGARN-UHFFFAOYSA-N n-methyl-2-(1-methylimidazol-4-yl)ethanamine Chemical compound CNCCC1=CN(C)C=N1 RGYJBKFFLRGARN-UHFFFAOYSA-N 0.000 description 1
- FHWNNTJVSHVFAF-UHFFFAOYSA-N n-methyl-2-(1-methylpyrrol-2-yl)ethanamine Chemical compound CNCCC1=CC=CN1C FHWNNTJVSHVFAF-UHFFFAOYSA-N 0.000 description 1
- QRELLYHYYPOENK-UHFFFAOYSA-N n-methyl-2-(1-oxidopyridin-1-ium-3-yl)ethanamine Chemical compound CNCCC1=CC=C[N+]([O-])=C1 QRELLYHYYPOENK-UHFFFAOYSA-N 0.000 description 1
- FEDMSAFHTABJGG-UHFFFAOYSA-N n-methyl-2-(4,5,6,7-tetrahydro-1-benzothiophen-3-yl)ethanamine Chemical compound C1CCCC2=C1SC=C2CCNC FEDMSAFHTABJGG-UHFFFAOYSA-N 0.000 description 1
- QUGIPZIKYUZUKS-UHFFFAOYSA-N n-methyl-2-(4-methyl-1,3-thiazol-5-yl)ethanamine Chemical compound CNCCC=1SC=NC=1C QUGIPZIKYUZUKS-UHFFFAOYSA-N 0.000 description 1
- PCWWEXBFZUKBRS-UHFFFAOYSA-N n-methyl-2-(5-methyl-1-benzothiophen-3-yl)ethanamine Chemical compound C1=C(C)C=C2C(CCNC)=CSC2=C1 PCWWEXBFZUKBRS-UHFFFAOYSA-N 0.000 description 1
- IKSCPAWBLQEUAG-UHFFFAOYSA-N n-methyl-2-thiophen-2-ylethanamine Chemical compound CNCCC1=CC=CS1 IKSCPAWBLQEUAG-UHFFFAOYSA-N 0.000 description 1
- SATDVGXJBKLPOT-UHFFFAOYSA-N n-methyl-2-thiophen-3-ylethanamine Chemical compound CNCCC=1C=CSC=1 SATDVGXJBKLPOT-UHFFFAOYSA-N 0.000 description 1
- UNUUERBHCKDOEI-UHFFFAOYSA-N n-methyl-3-thiophen-2-ylpropan-1-amine Chemical compound CNCCCC1=CC=CS1 UNUUERBHCKDOEI-UHFFFAOYSA-N 0.000 description 1
- XYRGYEWDSSZJAB-UHFFFAOYSA-N n-methyl-4-thiophen-2-ylbutan-1-amine Chemical compound CNCCCCC1=CC=CS1 XYRGYEWDSSZJAB-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- SUSQOBVLVYHIEX-UHFFFAOYSA-N o-phenylene-diaceto-nitrile Natural products N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- FKKJJPMGAWGYPN-UHFFFAOYSA-N thiophen-2-ylmethanamine Chemical compound NCC1=CC=CS1 FKKJJPMGAWGYPN-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19853519735 DE3519735A1 (de) | 1985-06-01 | 1985-06-01 | Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE19853522552 DE3522552A1 (de) | 1985-06-24 | 1985-06-24 | Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
NO862159L true NO862159L (no) | 1986-12-02 |
Family
ID=25832780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO862159A NO862159L (no) | 1985-06-01 | 1986-05-30 | Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater. |
Country Status (13)
Country | Link |
---|---|
US (1) | US4737495A (da) |
EP (1) | EP0204349A3 (da) |
KR (1) | KR870000323A (da) |
AU (1) | AU585351B2 (da) |
DK (1) | DK255086A (da) |
ES (2) | ES8704938A1 (da) |
FI (1) | FI79846C (da) |
GR (1) | GR861419B (da) |
HU (1) | HUT43587A (da) |
IL (1) | IL78970A (da) |
NO (1) | NO862159L (da) |
NZ (1) | NZ216360A (da) |
PT (1) | PT82661B (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4972273A (en) * | 1984-10-15 | 1990-11-20 | Burkhardt Norman S | High speed, high resolution image processing system |
DE3631013A1 (de) * | 1986-09-12 | 1988-03-24 | Thomae Gmbh Dr K | Neue naphthylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
GB8707120D0 (en) * | 1987-03-25 | 1987-04-29 | Pfizer Ltd | Antiarrhythmic agents |
JP2807577B2 (ja) * | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
CA2112360A1 (en) * | 1991-06-28 | 1993-12-23 | William Edward Bondinell | Bicyclic fibrinogen antagonists |
US5939412A (en) * | 1992-06-26 | 1999-08-17 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
US6458784B1 (en) | 1994-06-29 | 2002-10-01 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
US5977101A (en) * | 1995-06-29 | 1999-11-02 | Smithkline Beecham Corporation | Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity |
US20030125317A1 (en) * | 1996-10-02 | 2003-07-03 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
EP2332921B1 (en) | 2003-06-17 | 2016-03-02 | Arena Pharmaceuticals, Inc. | 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride |
EP1633720A1 (en) | 2003-06-17 | 2006-03-15 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
BRPI0414268B8 (pt) | 2003-09-19 | 2021-05-25 | Janssen Pharmaceutica Nv | ácidos 4-((fenoxialquil)tio)-fenoxiacéticos, análogos, e composições farmacêuticas |
FR2868776B1 (fr) | 2004-04-13 | 2008-04-18 | Servier Lab | Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2868775B1 (fr) * | 2004-04-13 | 2008-04-11 | Servier Lab | Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2868777B1 (fr) * | 2004-04-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
JP4886700B2 (ja) | 2004-12-23 | 2012-02-29 | アリーナ ファーマシューティカルズ, インコーポレイテッド | 5ht2cレセプターモジュレーターの組成物およびその使用方法 |
JO3006B1 (ar) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
CN101466684B (zh) | 2006-04-03 | 2012-06-20 | 艾尼纳制药公司 | 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体 |
UY30288A1 (es) | 2006-04-18 | 2007-08-31 | Janssen Pharmaceutica Nv | Derivados del ácido benzoazepin-oxi-acético como agonistas de ppar-delta usados para aumentar hdl-c. reducir ldl-c y reducir colesterol |
ES2522587T3 (es) | 2006-12-05 | 2014-11-17 | Arena Pharmaceuticals, Inc. | Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma |
EP2288585A1 (en) | 2008-03-04 | 2011-03-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
FR2932800B1 (fr) * | 2008-06-20 | 2015-02-20 | Servier Lab | Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
US20090320724A1 (en) * | 2008-06-27 | 2009-12-31 | Walburn William L | Swivel base with installation aid |
CN101774969B (zh) | 2009-01-13 | 2012-07-04 | 江苏恒瑞医药股份有限公司 | 硫酸伊伐布雷定及其i型结晶的制备方法 |
CN102648170A (zh) | 2009-06-18 | 2012-08-22 | 艾尼纳制药公司 | 制备5-ht2c受体激动剂的方法 |
KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ht2c 수용체 아고니스트의 제조 방법 |
EA201390335A1 (ru) | 2010-09-01 | 2013-09-30 | Арена Фармасьютикалз, Инк. | Введение лоркасерина индивидуумам с почечной недостаточностью |
CA2808904A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-ht2c agonists |
CA2808909A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
KR101913442B1 (ko) | 2010-09-01 | 2018-10-30 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태 |
AU2012392187B2 (en) | 2012-10-09 | 2018-07-12 | Arena Pharmaceuticals, Inc. | Method of weight management |
FR3003859B1 (fr) * | 2013-03-26 | 2015-03-13 | Servier Lab | "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine" |
AU2022328217A1 (en) | 2021-08-12 | 2024-03-14 | Kuleon Llc | Hallucinogenic and non-hallucinogenic serotonin receptor agonists and methods of making and using the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4490369A (en) * | 1981-05-19 | 1984-12-25 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Benzazepine derivatives, their pharmaceutical compositions and method of use |
DE3119874A1 (de) * | 1981-05-19 | 1982-12-09 | Dr. Karl Thomae Gmbh, 7950 Biberach | "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel" |
DE3343801A1 (de) * | 1983-12-03 | 1985-06-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue indolderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
-
1986
- 1986-05-21 EP EP86107836A patent/EP0204349A3/de not_active Withdrawn
- 1986-05-28 KR KR860004183A patent/KR870000323A/ko not_active Application Discontinuation
- 1986-05-28 PT PT82661A patent/PT82661B/pt not_active IP Right Cessation
- 1986-05-29 FI FI862270A patent/FI79846C/fi not_active IP Right Cessation
- 1986-05-30 ES ES555513A patent/ES8704938A1/es not_active Expired
- 1986-05-30 NZ NZ216360A patent/NZ216360A/xx unknown
- 1986-05-30 US US06/868,986 patent/US4737495A/en not_active Expired - Fee Related
- 1986-05-30 NO NO862159A patent/NO862159L/no unknown
- 1986-05-30 AU AU58216/86A patent/AU585351B2/en not_active Ceased
- 1986-05-30 IL IL78970A patent/IL78970A/xx not_active IP Right Cessation
- 1986-05-30 DK DK255086A patent/DK255086A/da not_active Application Discontinuation
- 1986-05-30 HU HU862287A patent/HUT43587A/hu unknown
- 1986-05-30 GR GR861419A patent/GR861419B/el unknown
-
1987
- 1987-01-09 ES ES557286A patent/ES8800202A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
US4737495A (en) | 1988-04-12 |
KR870000323A (ko) | 1987-02-17 |
DK255086D0 (da) | 1986-05-30 |
EP0204349A3 (de) | 1990-01-03 |
ES8800202A1 (es) | 1987-10-16 |
AU585351B2 (en) | 1989-06-15 |
IL78970A (en) | 1990-06-10 |
ES557286A0 (es) | 1987-10-16 |
EP0204349A2 (de) | 1986-12-10 |
ES8704938A1 (es) | 1987-04-16 |
FI862270A (fi) | 1986-12-02 |
FI79846C (fi) | 1990-03-12 |
PT82661B (pt) | 1988-11-30 |
DK255086A (da) | 1986-12-02 |
AU5821686A (en) | 1986-12-04 |
HUT43587A (en) | 1987-11-30 |
FI862270A0 (fi) | 1986-05-29 |
NZ216360A (en) | 1989-05-29 |
GR861419B (en) | 1986-09-26 |
IL78970A0 (en) | 1986-09-30 |
PT82661A (de) | 1986-06-01 |
FI79846B (fi) | 1989-11-30 |
ES555513A0 (es) | 1987-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO862159L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater. | |
US4584293A (en) | Aminotetralin derivatives | |
CS201040B2 (en) | Method of producing etherified hydroxy-benzo-diheterocyclic compounds | |
US5955495A (en) | Method of treating diseases of the CNS | |
US4912115A (en) | Heteroaromatic amine derivatives, pharmaceutical compositions containing these compounds and processes for preparing them | |
HRP960349A2 (en) | Therapeutic agents | |
NO171017B (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive cykliske aminderivater | |
HU195813B (en) | Process for preparing 1,2-dihydro-2h-imidazo/4,5-b/quinolin-2-one derivatives i medical compositions containing them as active substance | |
CZ20013907A3 (cs) | 1-(p-Thienylbenzyl)imidazoly jako agonisté receptorů angiotensinu-(1-7), způsob jejich přípravy, jejich pouľití a farmaceutické přípravky, které je obsahují | |
KR20010049859A (ko) | β-카르볼린 화합물, 이를 제조하는 방법 및 이를함유하는 약제 조성물 | |
IE55156B1 (en) | Pharmacologically active pyrazolo(4,3-c)pyridines | |
US10246414B2 (en) | Allosteric modulators of CB1 cannabinoid receptors | |
CS229938B2 (en) | Production method imidazoline derivative | |
EP0640595A1 (en) | Novel substituted tertiary amino compound or salt thereof | |
NO874194L (no) | Fremgangsmaate ved fremstilling av dihydro-pyridinderivater | |
NO851950L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater. | |
AU596869B2 (en) | 2-(thio-linked)-pyridine-5-(4,5-dihydro-2-oxazolyl)-(thieno( 2,3-d)-imidazoles and -benzimidazoles), a process for their preparation, and their use | |
FI88299B (fi) | Foerfarande foer framstaellning av farmaceutiskt anvaendbara cykliska aminderivat | |
NO780050L (no) | Fremgangsmaate ved fremstilling av 4,5,6,7-tetrahydrothieno-(2,3-c) og (3,2-c)pyridiner | |
DK166584B1 (da) | Substituerede 4-benzyl-1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem | |
EP0354788B1 (en) | Novel imidazole derivatives | |
NO845169L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater | |
DD247898A5 (de) | Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
US4616011A (en) | Novel indole derivatives and pharmaceutical compositions containing same | |
KR900000671B1 (ko) | 2,2'-바이-1h-이미다졸 및 그의 제조방법 |